Fengfeng Xu
- Co-authors
- Benjamin D. HumphreysDhruti P. ChenJoseph V. BonventreVenkata SabbisettiNingning WangShan MouSaid Movahedi NainiTakaharu Ichimura
- Topics
- RNA modifications and cancer (3 papers)SARS-CoV-2 and COVID-19 Research (2 papers)COVID-19 Clinical Research Studies (2 papers)
- Partner nations
- ChinaUnited StatesNorway
In The Last Decade
Fengfeng Xu
11 papers receiving 409 citations
Peers
Comparison fields: 5 of 70
- Nephrology 169
- Molecular Biology 138
- Surgery 81
- Pulmonary and Respiratory Medicine 63
- Immunology 46
Countries citing papers authored by Fengfeng Xu
This map shows the geographic impact of Fengfeng Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fengfeng Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fengfeng Xu more than expected).
Fields of papers citing papers by Fengfeng Xu
This network shows the impact of papers produced by Fengfeng Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fengfeng Xu. The network helps show where Fengfeng Xu may publish in the future.
Co-authorship network of co-authors of Fengfeng Xu
This figure shows the co-authorship network connecting the top 25 collaborators of Fengfeng Xu. A scholar is included among the top collaborators of Fengfeng Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fengfeng Xu. Fengfeng Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 23 | |
| 3 | 10 | |
| 4 | 12 | |
| 5 | 12 | |
| 6 | 17 | |
| 7 | 1 | |
| 8 | 11 | |
| 9 | 33 | |
| 10 | 279 | |
| 11 | 16 |
About Fengfeng Xu
Fengfeng Xu is a scholar working on Cancer Research, Nephrology and Hepatology, having authored 11 papers that have together received 416 indexed citations. Recurring topics across this work include RNA modifications and cancer (3 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and COVID-19 Clinical Research Studies (2 papers). The work is most often cited by research in Nephrology (169 citations), Transplantation (9 citations) and Cancer Research (36 citations). Fengfeng Xu has collaborated with scholars based in China, United States and Norway. Frequent co-authors include Benjamin D. Humphreys, Dhruti P. Chen, Joseph V. Bonventre, Venkata Sabbisetti, Ningning Wang, Shan Mou, Said Movahedi Naini, Takaharu Ichimura, Joel Henderson and Vijay K. Kuchroo. Their work appears in journals such as Journal of Clinical Investigation, Scientific Reports and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.